← All Inspiremd, INC filings

Inspiremd, INC DEF 14A proxy statements

Proxy statements, covering the matters put to shareholders at the annual meeting — board elections, auditor ratification and executive pay.

NASDAQ
NSPR
Inspiremd, INC
DEF: InspireMD Announces 2026 Annual Meeting and Share Increase
InspireMD, Inc. has scheduled its 2026 Annual Meeting for June 3, 2026, to elect directors and seek approval to increase authorized common stock to 250 million shares.
NASDAQ
NSPR
Inspiremd, INC
DEFA14A: InspireMD Files Definitive Proxy Statement with SEC
InspireMD, Inc. files a definitive proxy statement with the Securities and Exchange Commission.
NASDAQ
NSPR
Inspiremd, INC
DEF: InspireMD Sets Date for 2025 Annual Stockholder Meeting, Outlines Key Proposals
InspireMD announces its 2025 Annual Meeting of Stockholders to be held on June 3, 2025, featuring proposals for director elections and auditor ratification.
NASDAQ
NSPR
Inspiremd, INC
DEFA14A: InspireMD Files Definitive Proxy Statement with SEC
InspireMD, Inc. files a definitive proxy statement with the Securities and Exchange Commission.
NASDAQ
NSPR
Inspiremd, INC
DEF 14A: InspireMD Sets Date for 2024 Annual Stockholder Meeting, Outlines Key Proposals
InspireMD, Inc. will hold its annual stockholder meeting on June 10, 2024, to vote on director elections, executive compensation, auditor ratification, and other business matters.